Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aisara Chansakul

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Radiologic Clinics of North America|November 6, 2022
Elder AbuseMihan Lee, Aisara Chansakul, Jessica A Rotman, et al.
Journal of the American College of Radiology : JACR|July 8, 2023
A Collaborative Emergency Medicine and Radiology Pulmonary Nodule Program: Identification of Associated Efficacy and OutcomesLynn G Jiang, Meghan Cahill, Aisara Chansakul, et al.
Human Vaccines & Immunotherapeutics|July 10, 2024
Economic burden of cardiorespiratory hospitalizations associated with respiratory syncytial virus among United States adults in 2017-2019Deesha A Patel, Zachary A Marcum, Aisara Chansakul, et al.
Injury|June 9, 2023
Mechanisms and weapons in physical elder abuse injuries: Findings from legally adjudicated casesTony Rosen, Brady Rippon, Alyssa Elman, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|October 27, 2025
Prevalence of Diagnosed Essential Tremor in the United States: An Administrative Claims-Based StudyJunji Lin, Rajesh Pahwa, Elan D Louis, et al.
Blood Advances|July 11, 2019
Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota compositionMatthew J Pianko, Sean M Devlin, Eric R Littmann, et al.
Leukemia & Lymphoma|October 25, 2022
A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapyKarthik Nath, Tala Shekarkhand, Meghan Salcedo, et al.
JAMA Oncology|April 15, 2021
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical TrialOla Landgren, Malin Hultcrantz, Benjamin Diamond, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Radiologic Clinics of North America|November 6, 2022
Elder AbuseMihan Lee, Aisara Chansakul, Jessica A Rotman, et al.
Journal of the American College of Radiology : JACR|July 8, 2023
A Collaborative Emergency Medicine and Radiology Pulmonary Nodule Program: Identification of Associated Efficacy and OutcomesLynn G Jiang, Meghan Cahill, Aisara Chansakul, et al.
Human Vaccines & Immunotherapeutics|July 10, 2024
Economic burden of cardiorespiratory hospitalizations associated with respiratory syncytial virus among United States adults in 2017-2019Deesha A Patel, Zachary A Marcum, Aisara Chansakul, et al.
Injury|June 9, 2023
Mechanisms and weapons in physical elder abuse injuries: Findings from legally adjudicated casesTony Rosen, Brady Rippon, Alyssa Elman, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|October 27, 2025
Prevalence of Diagnosed Essential Tremor in the United States: An Administrative Claims-Based StudyJunji Lin, Rajesh Pahwa, Elan D Louis, et al.
Blood Advances|July 11, 2019
Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota compositionMatthew J Pianko, Sean M Devlin, Eric R Littmann, et al.
Leukemia & Lymphoma|October 25, 2022
A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapyKarthik Nath, Tala Shekarkhand, Meghan Salcedo, et al.
JAMA Oncology|April 15, 2021
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical TrialOla Landgren, Malin Hultcrantz, Benjamin Diamond, et al.
Pageof 1